MTP - マイダテック・ファ―マ (Midatech Pharma PLC)

MTPのニュース

   Midatech Pharma PLC - Grant of Options - Vox Markets  2020/06/17 06:00:00 VOX Markets
RNS Number: 1648 Q Midatech Pharma PLC 17 June 2020 17 June 2020. Midatech Pharma PLC, a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines announces that options over a total of 1,401,000 ordinary shares of 0.1 pence each in the capital Company have been granted to employees under the 2014 Midatech…
   Midatech Pharma PLC - Purported Termination of MTX110 Licence Agreement - Vox Markets  2020/06/09 15:04:00 VOX Markets
RNS Number: 4434 P Midatech Pharma PLC 09 June 2020 This Announcement contains inside information for the purposes of Article 7 of EU Regulation 596/ 2014. Upon the publication of this Announcement, this inside information is now considered to be in the public domain.. Purported Termination of MTX110 Licence Agreement.
   Midatech Pharma : Letter to Deyan Spiridonov re Midatech | MarketScreener  2020/06/09 09:23:06 MarketScreener
WAYNE F. DENNISON direct dial: 856-8247 wdennison@brownrudnick.com June 8, 2020 BY E-MAIL and … | June 9, 2020
   CMS Medical Venture - Form 8.3 - Midatech Pharma plc - Vox Markets  2020/06/09 07:10:00 VOX Markets
RNS Number: 3817 P CMS Medical Venture Inv Ltd 09 June 2020 FORM 8.3. PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY. A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE.
   Midatech enters research collaboration with Dr Reddy's  2020/06/08 12:00:57 Share Cast
Biotechnology research and development company Midatech Pharma has entered into a research collaboration with generic drugs giant Dr Reddy's Laboratories, it announced on Monday.
   Gfinity, Xpediator and Midatech Pharma - Vox Markets  2020/05/20 12:43:20 VOX Markets
Gfinity talks about the multi-year agreement they have signed with Formula 1. Xpediator’s Pall-Ex in 3 million milestone. Midatech Pharma £3.8m fundraise to progress their clinical programme.
   Midatech Pharma PLC - US$3.0 Million Registered Direct Offering - Vox Markets  2020/05/18 13:08:00 VOX Markets
Midatech Pharma PLC Announces US $3.0 Million Registered Direct Offering. 18 May 2020- Midatech Pharma PLC, an R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, is pleased to announce that it has entered into definitive binding agreements with institutional investors for the purchase in a…
   The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies  2020/03/04 12:37:10 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 3) Acceleron Pharma Inc (NASDAQ: XLRN ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Fate Therapeutics Inc (NASDAQ: FATE ) (reacted to its fourth-quarter results) Forty Seven Inc (NASDAQ: FTSV ) IGM Biosciences Inc (NASDAQ: IGMS ) Inovio Pharmaceuticals Inc (NASDAQ: INO )( announced an accelerated timeline for COVID-19 vaccine development) Repro-Med Systems, Inc. (NASDAQ: KRMD ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 3) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) EXACT Sciences Corporation (NASDAQ: EXAS ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Midatech Pharma PLC-ADR (NASDAQ: MTP )(began trading on a reverse split adjusted basis) Mylan NV (NASDAQ: MYL ) Neuronetics Inc (NASDAQ: STIM )(announced its fourth-quarter results) Passage Bio Inc (NASDAQ: PASG )(IPOed last week) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TransMedics Group Inc (NASDAQ: TMDX )(reported its fourth-quarter results) VIVUS, Inc. (NASDAQ: VVUS ) Xeris Pharmaceuticals Inc (NASDAQ: XERS ) See Also: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates Stocks In Focus Takeda To Develop COVID-19 Treatments Takeda Pharmaceutical Co Ltd (NYSE: TAK ) said it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin to treat high-risk individuals with the viral infection.
   Midatech Pharma : Expands MTX110 DIPG Programme | MarketScreener  2020/03/02 07:18:14 MarketScreener
Midatech Expands MTX110 DIPG Programme Released : 02 Mar 2020 07:00 RNS Number : 6427E … | March 2, 2020
   Midatech Pharma : Notice of General Meeting | MarketScreener  2020/02/12 14:19:41 MarketScreener
Regulatory Story Go to market news section … | February 12, 2020
   Gfinity, Xpediator and Midatech Pharma - Vox Markets  2020/05/20 12:43:20 VOX Markets
Gfinity talks about the multi-year agreement they have signed with Formula 1. Xpediator’s Pall-Ex in 3 million milestone. Midatech Pharma £3.8m fundraise to progress their clinical programme.
   Midatech Pharma PLC - US$3.0 Million Registered Direct Offering - Vox Markets  2020/05/18 13:08:00 VOX Markets
Midatech Pharma PLC Announces US $3.0 Million Registered Direct Offering. 18 May 2020- Midatech Pharma PLC, an R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, is pleased to announce that it has entered into definitive binding agreements with institutional investors for the purchase in a…
   The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies  2020/03/04 12:37:10 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 3) Acceleron Pharma Inc (NASDAQ: XLRN ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Fate Therapeutics Inc (NASDAQ: FATE ) (reacted to its fourth-quarter results) Forty Seven Inc (NASDAQ: FTSV ) IGM Biosciences Inc (NASDAQ: IGMS ) Inovio Pharmaceuticals Inc (NASDAQ: INO )( announced an accelerated timeline for COVID-19 vaccine development) Repro-Med Systems, Inc. (NASDAQ: KRMD ) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 3) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) EXACT Sciences Corporation (NASDAQ: EXAS ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Midatech Pharma PLC-ADR (NASDAQ: MTP )(began trading on a reverse split adjusted basis) Mylan NV (NASDAQ: MYL ) Neuronetics Inc (NASDAQ: STIM )(announced its fourth-quarter results) Passage Bio Inc (NASDAQ: PASG )(IPOed last week) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TransMedics Group Inc (NASDAQ: TMDX )(reported its fourth-quarter results) VIVUS, Inc. (NASDAQ: VVUS ) Xeris Pharmaceuticals Inc (NASDAQ: XERS ) See Also: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates Stocks In Focus Takeda To Develop COVID-19 Treatments Takeda Pharmaceutical Co Ltd (NYSE: TAK ) said it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin to treat high-risk individuals with the viral infection.
   Midatech Pharma : Expands MTX110 DIPG Programme | MarketScreener  2020/03/02 07:18:14 MarketScreener
Midatech Expands MTX110 DIPG Programme Released : 02 Mar 2020 07:00 RNS Number : 6427E … | March 2, 2020
   Midatech Pharma : Notice of General Meeting | MarketScreener  2020/02/12 14:19:41 MarketScreener
Regulatory Story Go to market news section … | February 12, 2020

calendar